Cases & Deals

Kura Oncology establishes patent portfolio related to use of tipifarnib in treatment of certain squamous cell head and neck cancer patients

Clients Kura Oncology, Inc.

Jones Day represents Kura Oncology, Inc. in prosecution of patent portfolio directed to use of tipifarnib in treatment of certain squamous cell head and neck cancer patients.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.